DUSP6 and non-small cell lung carcinoma: Previous studies have confirmed that in NSCLC cells, knocking down DUSP6 results in enhanced ERK activation, whereas overexpressing DUSP6 leads to a decreased ERK activation and enhanced cell apoptosis (Zhang et al. 2010).